Insider · CIK 0001859698

Ali Kevin

Reports to the SEC for 1 company · JERSEY CITY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001859698

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-05	OGNOrganon & Co.P Purchase	Director, Chief Executive Officer	PPurchase	+34K sh	$8.80	+$299K	282,731.157
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+48.8K sh	—	—	248,677.157
2025-03-31	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−27K sh	$14.51	−$391K	221,713.157
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+39K sh	—	—	260,687.157
2025-03-31	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−21.6K sh	$14.51	−$313K	239,134.157
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+21.5K sh	—	—	260,606.157
2025-03-31	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.9K sh	$14.51	−$172K	248,731.157
2025-03-31	OGNOrganon & Co. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.07M sh	—	—	1,072,607
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+218K sh	—	—	218,267
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−48.8K sh	—	—	97,518
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−39K sh	—	—	38,974
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−21.5K sh	—	—	0
2025-02-20	OGNOrganon & Co.A Award	Director, Chief Executive Officer	AAward	+84.2K sh	—	—	229,110
2025-02-20	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−46.6K sh	$14.92	−$695K	182,535
2025-02-20	OGNOrganon & Co.A Award	Director, Chief Executive Officer	AAward	+15.4K sh	—	—	197,958
2025-02-20	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−8,529 sh	$15.29	−$130K	199,919.157
2024-09-03	OGNOrganon & Co.A Award	Director, Chief Executive Officer	AAward	+21.6K sh	—	—	156,815
2024-09-03	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.9K sh	$20.35	−$243K	144,888
2024-05-04	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+22.2K sh	—	—	147,504
2024-05-04	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.3K sh	$19.61	−$240K	135,248
2024-05-04	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−22.2K sh	—	—	0
2024-03-31	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+21.5K sh	—	—	119,797
2024-03-31	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.9K sh	$18.80	−$223K	107,923
2024-03-31	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+39K sh	—	—	146,896
2024-03-31	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−21.6K sh	$18.80	−$405K	125,343
2024-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−21.5K sh	—	—	21,472
2024-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−39K sh	—	—	77,948
2024-03-29	OGNOrganon & Co. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+146K sh	—	—	146,276
2024-03-29	OGNOrganon & Co. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+599K sh	—	—	599,128
2024-02-28	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+88.1K sh	—	—	138,740
2024-02-28	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−40.4K sh	$18.04	−$729K	98,326
2024-02-28	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−88.1K sh	—	—	0
2023-05-04	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+22.2K sh	—	—	62,873
2023-05-04	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.3K sh	$24.24	−$297K	50,619
2023-05-04	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−22.2K sh	—	—	22,161
2023-05-01	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,711 sh	—	—	42,206
2023-05-01	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,491 sh	$24.63	−$36.7K	40,715
2023-05-01	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,711 sh	—	—	0
2023-03-31	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+21.5K sh	—	—	51,390
2023-03-31	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11.9K sh	$23.09	−$275K	39,495
2023-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−21.5K sh	—	—	42,943
2023-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+117K sh	—	—	116,921
2023-03-31	OGNOrganon & Co. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+420K sh	—	—	419,847
2023-02-28	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+11.4K sh	—	—	36,306
2023-02-28	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,387 sh	$25.09	−$160K	29,919
2023-02-28	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−11.4K sh	—	—	0
2022-05-04	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+22.2K sh	—	—	37,167
2022-05-04	OGNOrganon & Co.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−12.3K sh	$32.44	−$398K	24,913
2022-05-04	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−22.2K sh	—	—	22,158
2022-05-03	OGNOrganon & Co.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,631 sh	—	—	16,279

Recent filings

Accepted (ET)
May 64
Ali Kevin0001821825-25-000025
SEC(opens sec.gov)
Apr 24
Ali Kevin0001859698-25-000006
SEC(opens sec.gov)
Feb 244
Ali Kevin0001859698-25-000004
SEC(opens sec.gov)
Sep 54
Ali Kevin0001821825-24-000102
SEC(opens sec.gov)
May 74
Ali Kevin0001821825-24-000062
SEC(opens sec.gov)

Companies

Organon & Co.Director, Chief Executive OfficerOGN

Address

C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33

JERSEY CITY, NJ, 07032